This invention provides supplemented tissue sealants, methods for their
production and use thereof. Disclosed are tissue sealants supplemented
with at least one cytotoxin or cell proliferation inhibiting composition.
The composition may be further supplemented with, for example, one or
more antibodies, analgesics, anticoagulants, anti-inflammatory compounds,
antimicrobial compositions, cytokines, drugs, growth factors,
interferons, hormones, lipids, deminearlized bone or bone morphogenetic
proteins, cartilage inducing factors, oligonucleotides polymers,
polysaccharides, polypeptides, protease inhibitors, vasoconstrictors or
vasodilators, vitamins, minerals, stabilizers and the like.